Home
Clinical Trials
Partial Response to PPI Treat...

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

Last Updated: 2011-02-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

275 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-02-28

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

NCT00795093

Gastroesophageal Reflux Disease (GERD)

COMPLETED

Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

NCT00394472

Gastroesophageal Reflux Disease (GERD)

COMPLETED PHASE2

Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

NCT00392002

Gastroesophageal Reflux

COMPLETED PHASE4

Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD

NCT00634023

GERD

COMPLETED

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

NCT00703534

GERD Acid Reflux Disease Heartburn +1 more

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroesophageal Reflux Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

274 GERD patients, partial responders to PPI treatment

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 6 month history of GERD symptoms
* Treated with unchanged optimized PPI treatment for any GERD indication during the last 4 weeks before enrollment
* Remaining GERD symptoms despite optimized PPI treatment
* Able to read and write in French, and able to comply with study requirements

Exclusion Criteria

* Patients that have not experienced any GERD symptom improvement at all during PPI treatment
* Involvement in the planning or conduct of the study
* Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months
* Prior surgery of the upper GI tract

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers